Anti Amyloid Beta Articles & Analysis

1 news found

Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease

(Nasdaq: VAXX), a company pioneering the development of a new class of immunotherapeutic vaccines, today announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. ...

Jun. 8, 2022

ByVaxxinit

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you